313 related articles for article (PubMed ID: 20420169)
1. [Paraneoplastic neurological syndrome--definition and history].
Inuzuka T
Brain Nerve; 2010 Apr; 62(4):301-8. PubMed ID: 20420169
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and management of paraneoplastic neurological syndromes].
Saji E; Kawachi I; Nishizawa M
Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
[TBL] [Abstract][Full Text] [Related]
3. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
5. Managing paraneoplastic neurological disorders.
de Beukelaar JW; Sillevis Smitt PA
Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of paraneoplastic neurological syndromes].
Tanaka K
Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic neurological syndromes in 2008].
Honnorat J
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
[TBL] [Abstract][Full Text] [Related]
8. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neurological syndromes: a review.
Toothaker TB; Rubin M
Neurologist; 2009 Jan; 15(1):21-33. PubMed ID: 19131854
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic neurological syndromes.
Honnorat J; Antoine JC
Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.
Giometto B; Grisold W; Vitaliani R; Graus F; Honnorat J; Bertolini G;
Arch Neurol; 2010 Mar; 67(3):330-5. PubMed ID: 20212230
[TBL] [Abstract][Full Text] [Related]
12. New concepts in paraneoplastic neurological syndromes.
Honnorat J; Viaccoz A
Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].
Ovadia H; Karussis D; Abramsky O
Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634
[TBL] [Abstract][Full Text] [Related]
14. Update on paraneoplastic neurological syndromes.
Didelot A; Honnorat J
Curr Opin Oncol; 2009 Nov; 21(6):566-72. PubMed ID: 19620862
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic neurological syndromes: from the diagnosis of exclusion to the use of immunological and molecular markers].
Dalmau J
Neurologia; 2000 Mar; 15(3):114-26. PubMed ID: 10846872
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic neurological syndromes: diagnosis and treatment.
Graus F; Dalmau J
Curr Opin Neurol; 2007 Dec; 20(6):732-7. PubMed ID: 17992098
[TBL] [Abstract][Full Text] [Related]
17. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
18. [Pareneoplastic neurological syndrome --update].
Inuzuka T; Hayashi Y; Kimura A
Rinsho Shinkeigaku; 2011 Nov; 51(11):834-7. PubMed ID: 22277385
[TBL] [Abstract][Full Text] [Related]
19. [Paraneoplastic neurological syndromes].
Storstein A; Vedeler CA
Tidsskr Nor Laegeforen; 2009 Mar; 129(6):524-8. PubMed ID: 19282889
[TBL] [Abstract][Full Text] [Related]
20. Immunological markers in neurological disorders.
Karim AR; Jacob S
Ann Clin Biochem; 2012 Jan; 49(Pt 1):29-43. PubMed ID: 22113957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
